Supplemental Experimental Procedures

Cells and Reagents
MEFs, 293T cells and MCF7 cells were cultured in DMEM supplemented with 10% FBS (HyClone). 4-Hydroxy-tamoxifen was from Sigma-Aldrich. For siRNA studies, MEFs, NIH3T3 cells and MCF7 cells were transfected using Lipofectamine 2000 (Invitrogen).
Transfection efficiency was verified using BLOCK-IT Fluorescent oligo (Invitrogen).
Small inhibitory RNAs (used at a final concentration of 40 nM); negative control siRNA (medium GC), mouse Foxo3 and Cited2 Stealth siRNAs, and human FOXO3a, HIF1, NIX and RTP801 Stealth siRNA, are from Invitrogen.
Western Blotting and Antibodies
Cells were washed twice with PBS and lysed in lysis buffer (1% NP-40, 20 mM Tris-HCl (pH 8.0), 137 mM NaCl, 10 mM EDTA, 0.1 M NaF, 10% glycerol, protease inhibitors; Roche). Cell lysates were subjected to SDS-polyacrylamide gel electrophoresis using precast Novex Tris-Glycine gels (Invitrogen) and electrotransferred to Immobilon-FL transfer membranes (Millipore). Membranes were blocked in 50% PBS -50% Odyssey 
Luciferase Reporter Assays
NIH3T3 or 293T cells were seeded in 6 well plates at a density of 2 x 10 5 per well. Cells were transfected next day with 1 µg control or a FOXO3a(A3) expression plasmid, 1 µg luciferase reporter construct (pGL3), and 0.125 µg β-galactosidase plasmid DNA. After stimulation, cells were washed twice with PBS and lysed in 250 µl reporter lysis buffer (Promega). Luciferase activity was measured using the Luciferase Assay System kit (Promega). β-galactosdioase activity was analyzed using a β-galactosidase enzyme assay system kit (Promega). The human 3.5 kb CITED2 promoter fragment is present in the pGL3 basic reporter plasmid. The mouse Cited2 promoter (-1128/+238) was cloned in pGL3-basic (Promega) using the following primers:
forward 5'-CCTATTGCTCCACTGAACAAT-3', reverse 5'-CTCACCTTCCGTCTTTGCGATTTC-3', using the Expand High Fidelity PCR System (Roche). The -872 DBE in the Cited2 promoter was mutated using forward primer 5'-gat cgc tga gtt taa ata cag agc agg gac-3'. Mutations were made using the Quickchange Site Directed Mutagenesis kit (Stratagene) according to the manufacturer's instructions.
Chromatin Immunoprecipitation (ChIP) Assays
ChIP assays were performed using MEFs (~20x10 6 per condition) and an acetyl-histone H3 immunoprecipitation kit according to manufacturer's instructions (Upstate). Primers used are listed in Table S1 . Antibodies used to precipitate complexes harboring HAFOXO3a (HA-probe) or c-myc (Ig control) were obtained from Santa Cruz.
RNA Isolation, cDNA Synthesis, and qPCR
Cytoplasmic RNA was extracted from cells as described previously (Bakker et al., 2007) .
cDNA synthesis was performed in a total volume of 25 µl. RNA (10 µg) was treated with 10 U DNAse I (Stratagene) in DNAse buffer (40 mM Tris-HCl pH 7.5, 6 mM MgCl 2 , 2 mM CaCl 2 ) for 45 min, followed by 10 min at 70°C. DNAse-treated RNA (1 µg) was mixed with 2 µl dNTPs (10 mM) and 0. Ribonuclease inhibitor or ribosomal protein S18 were used for normalization. Primers used are listed in Table S1 .
